{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
US Previously Marketed
Source:
Neumega
(1997)
Source URL:
First approved in 1997
Source:
Neumega
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
MYOSCINT by CENTOCOR INC
(1996)
Source URL:
First approved in 1996
Source:
MYOSCINT by CENTOCOR INC
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
TRASYLOL by BAYER HLTHCARE
(1993)
Source URL:
First approved in 1993
Source:
TRASYLOL by BAYER HLTHCARE
Source URL:
Class:
PROTEIN
Status:
First approved in 1991
Class:
PROTEIN
Status:
US Previously Marketed
Source:
BOTOX
(1991)
Source URL:
First approved in 1991
Source:
BOTOX
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
ADAGEN by LEADIANT BIOSCI INC
(1990)
Source URL:
First approved in 1990
Source:
ADAGEN by LEADIANT BIOSCI INC
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
CIBACALCIN by NOVARTIS
(1986)
Source URL:
First approved in 1986
Source:
CIBACALCIN by NOVARTIS
Source URL:
Class:
PROTEIN
Status:
First approved in 1985
Class:
PROTEIN
Status:
First approved in 1955
Class:
PROTEIN
Status:
First approved in 1953
Class:
PROTEIN